Form D · Other Technology
Leo Health, Inc.
New York, NY · CIK 0001675735
Offering snapshot reported Nov 10, 2016 · SEC filing
- Reported sold
- $2.5M Offering amount: $2.5M
- Investors reported
- 36 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 24, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 10, 2016 | Initial | $2,499,976 | No comparison | 36 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $27K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-274290
Preferred Stock
Excludes warrants to purchase up to 4,520 shares.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| SI Securities | 170937 |
Source: Form D, filed Nov 10, 2016. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Benjamin Siscovick | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
16 W. 22 Nd St., 6 Th Floor
New York, NY, 10010
New York, NY, 10010